Now Organogenesis has signed a lease for the entire 122,000 square-foot facility. The lease was executed Nov. 18, two weeks ...

Canton, Mass.-based Organogenesis plans to invest nearly $100 million in a new manufacturing facility in Smithfield.

EST Organogenesis (ORGO) files to sell 130K shares of common stock for holdersPick the best stocks and maximize your portfolio:Discover ...

Wellington Management Group LLP boosted its stake in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) by 8.0% during ...

The Federal Reserve's recent rate cut indicates a stable yet slowing economy, with inflation sticking around but consumer ...

Fmr LLC grew its position in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) by 34.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor ...

About Organogenesis Holdings Inc. Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the ...

Morgan Stanley assumed coverage of Organogenesis (ORGO) with an Equal Weight rating and an unchanged price target of $4. Organogenesis has an ...

CANTON, Mass., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development ...

As the Nasdaq Composite reaches new heights and Bitcoin surges to unprecedented levels, the U.S. market is experiencing a mix of optimism and caution, with investors keenly watching upcoming Federal ...

市值4.7亿美元的医疗保健公司Organogenesis Holdings Inc. (NASDAQ:ORGO)在过去六个月内股价飙升38%。该公司总裁兼首席执行官Gary S. Gillheeney最近报告出售了价值206,358美元的公司股份。根据 InvestingPro ...

根据 InvestingPro 的数据，Organogenesis Holdings Inc. (NASDAQ:ORGO)的总裁兼首席执行官Gary S. Gillheeney最近进行了几笔涉及公司股票的交易。ORGO的股票显示出显著的波动性，尽管最近有所回落，但在过去六个月内仍上涨了31.6%。12月5日，Gillheeney行权获得了1,067,245股A类普通股，每股价格为0.99美元。随后 ...